… of cancer immunotherapies based on immune checkpoint inhibitors and CAR T … cancers
and how they can be manipulated to take advantage of these tissue-resident innate lymphocytes …

Immunotherapies have revolutionized cancer treatment over the last 20 years. They aim
either to boost immune cell activation or decrease immune cell inhibition, to improve control …

… ICs are also expressed on innate lymphoid cells (ILC), drawing interest from the field to
understand their function, impact for anti-tumor immunity and potential for immunotherapy. In this …

Immuno-oncology is an emerging field that has revolutionized cancer treatment. Most
immunomodulatory strategies focus on enhancing T cell responses, but there has been a recent …

… Innate lymphoid cells (ILCs) are a heterogeneous immune cell population identified in the
late 2000's by several teams (1–8). Previously known lymphoid tissue inducer (LTI) cells and …

… stimulate tumor outgrowth or aid in a subsequent metastatic cascade. Innate lymphoid cells
(… , although the nature of their responses in cancer has only recently begun to be unveiled. …

… regulators of cancer immunology. ILCs as the most innate cells across the innate-adaptive …
as transcriptional state of each cell type with adaptive cells on the one end and ILCs on the …

… These findings reveal a tumor-elicited immunosurveillance … type-1-like innate lymphoid cells
and type 1 innate-like T cells. … type 1-like innate lymphoid cells and type 1 innate-like T cells. …

… a family of immune cells termed “innate lymphoid cells,” which straddle these two arms. Eberl
et al. review current understanding of innate lymphoid cells. Like innate immune cells, they …

… Taken together, targeting ILCs for cancer immunotherapy could be a … Innate lymphoid cells
(ILCs) are considered a parallel lineage of innate immune cells to conventional T and B cells […